DTE-10670-00570
2 vaccinations
6 coded responses
11 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 170 / PA
- Registered
- 2021-08-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-06
Dose 1 — Pfizer-BioNTech
-
2021-07-30
Dose 2 — Pfizer-BioNTech
-
2021-08-01
Registered in v-safe
-
2021-08-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Muscle or body achesAdult check-in
-
2021-08-02
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain, Injection site paraesthesia, Oedema peripheral, Paraesthesia — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesFree text: Lower underarm swelling and severe pain. Strange tingling sensations starting at injection site then other areas randomlyMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-04
Survey response — days 1–6 daily, dose 2MedDRA: Abdominal pain lower — Feeling: Good · Site: Pain, Redness, Swelling · Muscle or body aches, Abdominal pain · Be unable to do your normal daily activitiesFree text: Extremely low abdominal pain when standing/walking. Like menstrual cramping but lowerMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-05
Survey response — days 1–6 daily, dose 2MedDRA: Abdominal pain lower, Myalgia, Pain — Feeling: Fair · Site: Pain, Redness, Itching · Abdominal painFree text: Extremely low abdomen/muscle pain upon standing or walking simular to menstrual cramps but much lowerMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-06
Health check-in — day 7, dose 2Feeling: Fair · Site: Pain, Itching · Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-08-14
Survey response — day 14, dose 2MedDRA: Myalgia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Severe muscle aches/soreness for approx 24-48 hoursMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-20
- 2021-08-29
-
2021-09-12
Survey response — day 42, dose 2MedDRA: Exposure to SARS-CoV-2, Fatigue — Feeling: FairFree text: Fatigue and tiredness. I was protected against a breakthrough covid infection positive exposure in my homeMedDRA releases: 2024-11 · check-in free text available
- 2021-10-29
-
2022-01-29
Survey response — 6 months, dose 2MedDRA: Body temperature increased, Fatigue, Nasal congestion, Rhinorrhoea, Sneezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Runny/stuffy nose, sneezing, tired, elevated temperature (24 hrs) fatigue after immediate activity. No test done but we believe we contracted covid 12/24/21 from son's coworker.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-06 | Pfizer-BioNTech | No |
| 2 | 2021-07-30 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Lower underarm swelling and severe pain. Strange tingling sensations starting at injection site then other areas randomly
Systemic reaction (other): Extremely low abdominal pain when standing/walking. Like menstrual cramping but lower
Systemic reaction (other): Extremely low abdomen/muscle pain upon standing or walking simular to menstrual cramps but much lower
Release 9 — day 14, dose 2
Symptoms: Severe muscle aches/soreness for approx 24-48 hours
Release 9 — day 42, dose 2
Symptoms: Fatigue and tiredness. I was protected against a breakthrough covid infection positive exposure in my home
Release 11 — 6 months, dose 2
Symptoms: Runny/stuffy nose, sneezing, tired, elevated temperature (24 hrs) fatigue after immediate activity. No test done but we believe we contracted covid 12/24/21 from son's coworker.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Body temperature increased | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Myalgia | ✓ | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Abdominal pain lower | ✓ | · | ✓ |
| SRO | Axillary pain | ✓ | · | ✓ |
| SRO | Injection site paraesthesia | ✓ | · | ✓ |
| SRO | Myalgia | ✓ | · | ✓ |
| SRO | Oedema peripheral | ✓ | · | ✓ |
| SRO | Pain | ✓ | · | ✓ |
| SRO | Paraesthesia | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release